Teixeira Carla A, Espinola Janice, Huo Liang, Kohlschütter Johannes, Persaud Sawin Dixie-Ann, Minassian Berge, Bessa Carlos J P, Guimarães A, Stephan Dietrich A, Sá Miranda Maria Clara, MacDonald Marcy E, Ribeiro Maria Gil, Boustany Rose-Mary N
Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
Hum Mutat. 2003 May;21(5):502-8. doi: 10.1002/humu.10207.
The neuronal ceroid lipofuscinoses (NCLs) are a heterogeneous group of autosomal recessive neurodegenerative diseases comprising Batten and other related diseases plus numerous variants. They are characterized by progressive neuronal cell death. The CLN6 gene was recently identified, mutations in which cause one of the variant late infantile forms of NCL (vLINCL). We describe four novel mutations in the CLN6 gene. This brings the total number of CLN6 mutations known to 11 in 38 families. This suggests that the CLN6 gene may be highly mutable. An American patient of Irish/French/Native American origin was heterozygous for a 4-bp insertion (c.267_268insAACG) in exon 3. The other allele had a point mutation (c.898T>C) in exon 7 resulting in a W300R amino acid change. Two Trinidadian siblings of Indian origin were homozygous for a mutation at the 5' donor splice site of exon 4 (IVS4+1G>T), affecting the first base of the invariant GT at the beginning of intron 4. The fourth novel mutation, a double deletion of 4 bp and 1 bp in exon 7 (c.829_832delGTCG;c.837delG), was identified in a Portuguese patient heterozygous for the I154del Portuguese CLN6 mutation. Four of the 11 mutations identified are in exon 4. Three Portuguese patients with clinical profiles similar to CLN6 patients without defects in CLN6 or other known NCL genes are described. We conclude the following: 1) the CLN6 gene may be a highly mutable gene; 2) exon 4 must code for a segment of the protein crucial for function; 3) vLINCL disease in Portugal is genetically heterogeneous; 4) the I154del accounts for 81.25% of affected CLN6 Portuguese alleles; and 5) three vLINCL Portuguese patients may have defects in a new NCL gene.
神经元蜡样脂褐质沉积症(NCLs)是一组常染色体隐性神经退行性疾病,包括巴顿病及其他相关疾病以及众多变体。其特征为进行性神经元细胞死亡。CLN6基因最近被鉴定出来,该基因的突变会导致一种变体晚发性婴儿型NCL(vLINCL)。我们描述了CLN6基因的四个新突变。这使得在38个家族中已知的CLN6突变总数达到了11个。这表明CLN6基因可能具有高度的变异性。一名具有爱尔兰/法国/美洲原住民血统的美国患者在第3外显子中杂合了一个4碱基插入(c.267_268insAACG)。另一个等位基因在第7外显子中有一个点突变(c.898T>C),导致W300R氨基酸改变。两名具有印度血统的特立尼达岛同胞在第4外显子的5'供体剪接位点(IVS4+1G>T)发生了纯合突变,影响了内含子4起始处不变的GT的第一个碱基。在一名携带I154del葡萄牙CLN6突变的杂合葡萄牙患者中鉴定出了第四个新突变,即第7外显子中4个碱基和1个碱基的双重缺失(c.829_832delGTCG;c.837delG)。在已鉴定的11个突变中,有4个位于第4外显子。描述了三名临床特征与CLN6患者相似但CLN6及其他已知NCL基因无缺陷的葡萄牙患者。我们得出以下结论:1)CLN6基因可能是一个高度可变的基因;2)第4外显子必定编码对功能至关重要的一段蛋白质;3)葡萄牙的vLINCL疾病在遗传上具有异质性;4)I154del占受影响的CLN6葡萄牙等位基因的81.25%;5)三名vLINCL葡萄牙患者可能在一个新的NCL基因中存在缺陷。